Effects of URI on Diabetic Subjects Utilizing Technosphere Insulin After a Meal Challenge

MannKind

Status: Completed

Conditions: Diabetes Mellitus; Upper Respiratory Infection

Treatments: Drug: Technosphere Insulin

Study type: Observational

Funder types: Industry

Identifiers

NCT00642681

MKC-TI-112

Details and patient eligibility

About

Effect of upper respiratory infection (URI) on diabetic subjects with a meal challenge

Enrollment: 20 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects will have met the same inclusion criteria as MKC-TI-030
• Clinical diagnosis of URI with in 24 hrs prior to clinic visit and/or day of clinic visit
• At least 3 URI symptoms

Exclusion criteria

• Prior participation in MKC-TI-112
• MedHist, PE or lab findings of acute bacterial infection including but not limited to sputum prod., nasal/eye discharge, chest exam abnormalities, CXR findings of pneumonia.

Trial design

20 participants in 1 patient group

1: TI Inhalation Powder

Description:

Technosphere® Insulin (TI) Inhalation Powder

Treatment:

Drug: Technosphere Insulin